Memorial Sloan-Kettering Cancer Center (MSKCC)
See the following -
Big Pharma Companies Open Up Cancer Trial Comparator Arm Data
A lot has changed in clinical trial transparency since Project Data Sphere outlined plans to share cancer results in 2012, with the European law voted in last week then still a distant threat. Even so, Pfizer ($PFE), Sanofi ($SNY) and the other groups behind the initiative think it still offers something different now that it has belatedly launched.
- Login to post comments
Big Pharma Opens New Chapter On Big Data Collaboration
In the course of one short week, no less than 3 different models have emerged for sharing big data in the pharmaceutical industry. The highest profile of these ‒ called Project Data Sphere (PDS here) ‒ was announced earlier today with the official opening of an online resource to share clinical trial data for use in cancer research.
- Login to post comments
Can Doctors Teach The Body To Cure Cancer?
Increasingly, doctors are using their patients' own immune systems as valuable weapons against the disease...
- Login to post comments
How Does an Entrepreneur Help His Fiancé Fight Cancer? With Open Source Tools, of Course.
My name is Jorge. I started Kanteron Systems, a medical imaging open-source software company, in Valencia (Spain) in 2005. In 2011 I moved to New York to open our US subsidiary. While living in New York, I started dating a woman that was battling breast cancer. Her name is Stephanie. Stephanie’s oncologist was at Beth Israel Cancer Center, her surgeon at Mount Sinai St. Luke’s Hospital, and her radiation therapist at Memorial Sloan-Kettering Cancer Center (MSKCC). As I held her hand through the process twice (she had surgery, and a recurrence a year later) and met with her doctors, I saw first-hand how broken many cancer-care processes involving data and medical imaging sharing were.